Konrad Klinghammer Selected Research

Konrad Klinghammer Research Topics

15	Squamous Cell Carcinoma of Head and Neck 01/2024 - 01/2010
11	Neoplasms (Cancer) 01/2022 - 08/2011
7	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 06/2015
1	Carcinoma (Carcinomatosis) 01/2023
1	Fatigue 01/2022
1	Uveal melanoma 01/2022
1	Hypoxia (Hypoxemia) 11/2020
1	Inflammation (Inflammations) 10/2020
1	Microsatellite Instability 01/2020
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2017
1	Infections 01/2016
1	Hypercapnia 01/2012
1	Exanthema (Rash) 01/2010

6	Cetuximab (Erbitux)FDA Link 01/2022 - 01/2010
5	Docetaxel (Taxotere)FDA Link 01/2022 - 01/2010
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2015
3	LigandsIBA 11/2016 - 01/2010
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2018
2	RNA (Ribonucleic Acid)IBA 10/2020 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2016 - 01/2010
1	pembrolizumabIBA 01/2024
1	Cancer VaccinesIBA 01/2024
1	Androgen Receptors (Androgen Receptor)IBA 01/2023
1	NivolumabIBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	src-Family KinasesIBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Disulfiram (Antabuse)FDA Link 01/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	Immune Checkpoint InhibitorsIBA 10/2020
1	NucleotidesIBA 10/2020
1	copanlisibIBA 10/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	InterferonsIBA 11/2016
1	SmokeIBA 01/2016
1	Everolimus FDA Link 06/2015
1	Formaldehyde (Formol)FDA Link 04/2015
1	DNA (Deoxyribonucleic Acid)IBA 04/2015
1	EnzymesIBA 01/2012
1	Carbon MonoxideIBA 01/2012
1	Heme Oxygenase-1IBA 01/2012
1	AmphiregulinIBA 08/2011
1	epidermal growth factor receptor VIIIIBA 08/2011
1	Monoclonal AntibodiesIBA 01/2010